RETROVIR is a nucleoside analogue reverse transcriptase inhibitor indicated for:* Treatment of Human Immunodeficiency Virus (HIV-1) infection in combination with other antiretroviral agents. (1.1) * Prevention of maternal-fetal HIV-1 transmission. (1.2)
Document Date
Tuesday, November 14, 2023